Daniel Liedtke has been CEO of the Hirslanden Group and a member of the Executive Committee of the Mediclinic Group since January 2019. The development of integrated physical and digital healthcare and operating models, as well as the management of networked healthcare facilities, have been the focus of Daniel Liedtke's work for decades. He is a member of numerous boards, is involved in teaching and research and is a passionate advocate of high-quality, cost-effective medicine and care.

Career

  • Since January 2019
    Chief Executive Officer, Hirslanden Group
  • 2015 – 2018
    Chief Operating Officer, Hirslanden Group
  • 2008 – 2015
    Hospital Manager, Klinik Hirslanden Zurich

Education

  • Advanced Management Program (AMP Harvard Business School, Boston)
  • Doctor of Business Administration (Charles Sturt University, Australia)
  • Executive Master of Science in Health Service Administration (EMSHA)
  • Osteopath D.O. (GDK)
  • Physiotherapist (BSc, State diploma)
  • Automotive electronics  engineer (State diploma)

Other activities and functions

Further information

  • Born in: 1970
  • Family: Father of five children

Vision for Healthcare Leadership

As a shaper, developer and leader in the healthcare system, my goal is to inspire and empower specialists and managers to lead and develop their business units and organisations boldly and responsibly, without losing sight of the healthcare system as a whole. A key element of this is recognising that individual patient care is a unique blend of science, art, empathy and business. It is essential to be aware of the specific features of the healthcare system in comparison with other countries and at regional level, as it is always a reflection of social, political and economic framework conditions. This adaptive approach not only guarantees the quality and cost-effectiveness of healthcare provision, but also ensures that it is tailored to the specific needs and circumstances of each country, region and population.